Alternatives to Bloods AI

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Harnessing genetic data for digital insights in rare and germline disorders.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.

Develops a computational model of the human body for drug discovery and development.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered diagnostic system for predictive analytics in healthcare.

Rapid bacterial identification and antibiotic susceptibility testing in under 45 minutes.

Next-generation molecular diagnostics for immediate and accurate pathogen detection anywhere.

AI-powered medical imaging solutions for sharper images, faster scans, and improved efficiency.

AI-powered real-time guidance and quality assessment for cardiac ultrasound imaging.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Developing AI-driven solutions for optimizing chronic condition treatment efficacy and tolerance.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Global network of clinics using AI and data science to treat age-related cognitive and functional decline.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Develops toilet-integrated diagnostic technology for early health condition detection.

Digital pathology imaging technology and AI-driven precision pathology software.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Global life sciences company providing diagnostic and biopharma laboratory services.

AI-driven platform for faster and more efficient diagnosis of women's health issues.

Leveraging the adaptive immune system to diagnose and treat disease.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

AI-powered medical technology revolutionizing sleep apnea diagnosis and treatment.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

Platform for managing high-risk populations prone to severe illnesses, enabling early diagnosis and cost reduction.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Developing AI-driven technology for mental health treatments, focusing on PTSD.

A medical platform connecting patients and physicians with genetic expertise.

AI company for anatomical inference and semi-automatic dense labeling of medical imaging.

AI-powered diagnostic imaging for early detection of diabetic retinopathy.

RADLogics develops AI-powered software analytics for medical imaging to enhance radiologists' productivity and diagnostic accuracy.

Sensifai desarrolla reconocimiento potenciado por IA, soluciones DeFi seguras y plataformas Web3 innovadoras.

AI-driven quality management system for radiology departments, reducing risk and improving financial efficacy.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Microbiome technology platform for developing novel therapeutics.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.